Mechanistic basis of post-treatment control of SIV after anti-α4β7 antibody therapy.

PLoS Computational Biology
Chad R WellsAlan S Perelson

Abstract

Treating macaques with an anti-α4β7 antibody under the umbrella of combination antiretroviral therapy (cART) during early SIV infection can lead to viral remission, with viral loads maintained at < 50 SIV RNA copies/ml after removal of all treatment in a subset of animals. Depletion of CD8+ lymphocytes in controllers resulted in transient recrudescence of viremia, suggesting that the combination of cART and anti-α4β7 antibody treatment led to a state where ongoing immune responses kept the virus undetectable in the absence of treatment. A previous mathematical model of HIV infection and cART incorporates immune effector cell responses and exhibits the property of two different viral load set-points. While the lower set-point could correspond to the attainment of long-term viral remission, attaining the higher set-point may be the result of viral rebound. Here we expand that model to include possible mechanisms of action of an anti-α4β7 antibody operating in these treated animals. We show that the model can fit the longitudinal viral load data from both IgG control and anti-α4β7 antibody treated macaques, suggesting explanations for the viral control associated with cART and an anti-α4β7 antibody treatment. This effective pertur...Continue Reading

References

May 16, 1998·Journal of Theoretical Biology·R J De Boer, A S Perelson
May 23, 1998·The Journal of Experimental Medicine·N SachsenbergL Perrin
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·T B Kepler, A S Perelson
Mar 16, 2000·Journal of Theoretical Biology·M A StaffordA S Perelson
Oct 12, 2000·Nature·E S RosenbergB D Walker
Aug 28, 2004·Journal of Virology·Miles P DavenportAlan S Perelson
May 17, 2006·Trends in Ecology & Evolution·Jerald B Johnson, Kristian S Omland
Aug 21, 2007·Journal of Pharmaceutical Sciences·James W T Yates, Philip A Arundel
Nov 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Hannah Yuan ChenLinqi Zhang
Nov 26, 2009·Proceedings of the National Academy of Sciences of the United States of America·Claudia CicalaJames Arthos
Sep 9, 2010·PLoS Computational Biology·Rob J De BoerAlan S Perelson
Dec 15, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aftab A AnsariFrancois Villinger
Mar 8, 2011·PLoS Computational Biology·Amber M SmithAlan S Perelson
Jun 30, 2012·Viral Immunology·Sonia NorrisMartin R Goodier
Jan 15, 2013·Journal of Theoretical Biology·Rob J De Boer, Alan S Perelson
Feb 1, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Krista G HaanstraEric R Fedyk
Mar 14, 2013·Sociological Methodology·Yu XieBen Jann
May 16, 2015·Cell·David J DiLillo, Jeffrey V Ravetch
Jul 25, 2015·Nature Reviews. Immunology·E John Wherry, Makoto Kurachi
Sep 24, 2015·Oncotarget·Jamie L SchaferR Keith Reeves
Jan 7, 2016·PLoS Computational Biology·Jessica M Conway, Alan S Perelson
Jul 16, 2016·PLoS Pathogens·Matthias HoffmannUNKNOWN SPARTAC and CHERUB Investigators
Feb 9, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Alexandre GirardStéphane Paul
Mar 16, 2017·Nature·Yoshiaki NishimuraMalcolm A Martin
Oct 12, 2018·PLoS Pathogens·Youfang CaoAlan S Perelson
Apr 3, 2019·Nature Medicine·Marina CaskeyMichel C Nussenzweig
Sep 7, 2019·Science·Jeremy Berg
Dec 9, 2020·Proceedings of the National Academy of Sciences of the United States of America·Livia R GoesJames Arthos

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

VISCONTI

Related Concepts